<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Glueck, Charles J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Treatment of Femoral Head Osteonecrosis: State of the Art</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">21-24</style></pages><abstract><style  face="normal" font="default" size="100%">Osteonecrosis of the femoral head (ONFH) is a multifactorial and heterogeneous group of disorders that leads to death of the femoral head. This session was devoted to an overview of treatment options for this debilitating disease. This article discusses issues related to etiology, pharmacological management, epigenetics, and surgical approaches to the treatment of osteonecrosis.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>